---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-210295"
form_type: "8-K"
ticker: "APLS"
cik: "0001492422"
company_name: "Apellis Pharmaceuticals, Inc."
filed_at: "2021-07-08T23:59:59+00:00"
generated_at: "2026-06-30T06:34:34.725275+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Apellis exchanges $198.6M in convertible notes for common stock; closing July 23

## Summary
- Agreed to exchange ~$198.6M principal of 3.500% Convertible Senior Notes due 2026 for shares.
- Fixed issuance of 4,530,431 shares (22.8065 per $1,000 principal) plus additional variable shares tied to VWAP.
- Exchange expected to close July 23, 2021, subject to customary conditions.
- Shares issued in private placement to QIBs and institutional accredited investors.

## SEC filing metadata
- accession: 0001193125-21-210295
- form_type: 8-K
- ticker: APLS
- cik: 0001492422
- company_name: Apellis Pharmaceuticals, Inc.
- filed_at: 2021-07-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1492422/000119312521210295/0001193125-21-210295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1492422/000119312521210295/d198376d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-210295
- JSON: https://secwatch.observer/filing/0001193125-21-210295.json
- Plain text: https://secwatch.observer/filing/0001193125-21-210295.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.